French government launches national action plan to promote use of generics

1 April 2015
marisol-touraine-big

The French government has launched a national action plan to promote the use of generic medicines, aiming for a saving of 350 million euros ($375 million) by 2017.

The Health Minister, Marisol Touraine, presented the proposals to public health organizations, patient advocacy groups, hospital federations, trade unions, academic groups, professional bodies and teachers. It aims to encourage the use of generics in the community, hospitals and nursing homes, and intends to remove obstacles to the use of generics. Major groups have signed a charter agreeing to adhere to the national plan. A national advertising campaign targeted at the general public and health professionals is to be launched at the end of 2015.

France lags behind global generics average

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Generics